Menu
Log in
Forgot password
Log in
Forgot password

News

  • Home
  • Resources
  • Literature Updates
  • Comparison of Pretreatment Strategies for cT2cN0 Staged Adenocarcinoma of the Esophagus and the Gastroesophageal Junction: A European High-Volume Center Cohort Analysis

Comparison of Pretreatment Strategies for cT2cN0 Staged Adenocarcinoma of the Esophagus and the Gastroesophageal Junction: A European High-Volume Center Cohort Analysis

25 Nov 2025 6:46 PM | Anonymous member (Administrator)

Naita M. Wirsik; Thomas Schmidt; Cezanne D. Kooij; Niall Dempster; Nerma Crnovrsanin; Noel E. Donlon; Eren Uzun; Kunal Bhanot; Henrik Nienhüser; Daniela Polette; Kammy Kewani, Peter Grimminger; Daniel Reim; Florian Seyfried; Hans F. Fuchs; Suzanne S. Gisbertz; Christoph-Thomas Germer; Jelle P. Ruurda; Fredrik Klevebro; Wolfgang Schröder; Magnus Nilsson; John V. Reynolds; Mark I. Van Berge Henegouwen; Sheraz Markar; Richard Van Hillegersberg; Christiane J. Bruns

Read Abstract: Comparison of Pretreatment Strategies for cT2cN0 Staged Adenocarcinoma of the Esophagus and the Gastroesophageal Junction: A European High-Volume Center Cohort Analysis

Affiliated Societies



International  Interdisciplinary  Everything Esophageal


The International Society for Diseases of the Esophagus is a 501(c)3 non-profit organization. © International Society for Disease of the Esophagus – ISDE 2024 | Any unauthorized use or reproduction of the content is prohibited without explicit permission.

General Inquiries: info@isde.net
Membership Questions: membership@isde.net

Powered by Wild Apricot Membership Software